organization

EORTC

European Organisation for Research and Treatment of Cancer
12 projects, page 1 of 3
  • project . 2015 - 2020
    Funder: EC Project Code: 635342
    Overall Budget: 4,948,740 EURFunder Contribution: 4,948,740 EUR
    Open Access mandate for Publications
    Partners: UNIVERSITA DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI, FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE, L'AZIENDA SOCIO SANITARIA TERRITORIALE (ASST) GRANDE OSPEDALE METROPOLITANO NIGUARDA, NKI ALV, AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA, KUL, Agendia NV, UNITO, ICO, EORTC...

    Colorectal cancer (CRC) is increasingly being recognized as a heterogeneous disease with distinct molecular subtypes. These subtypes have different biological processes at the basis of their disease and consequently their prognosis and responses to therapy are also diff...

  • project . 2022 - 2027
    Funder: EC Project Code: 101057482
    Overall Budget: 7,292,900 EURFunder Contribution: 7,235,020 EUR
    Open Access mandate for Publications and Research Data
    Partners: Institut Gustave Roussy, STICHTING INTEGRAAL KANKERCENTRUM NEDERLAND, FUNDATIA YOUTH CANCER EUROPE, EORTC, COI, ECCO, CLB, UM, FFUND BV, NKI ALV...

    STRONG-AYA is a new, interdisciplinary, multi-stakeholder European network to improve healthcare services, research and outcomes for Adolescents and Young Adults (AYA) with cancer, defined as individuals aged 15-39 years at cancer diagnosis. AYAs with cancer form a uniq...

  • project . 2019 - 2023
    Funder: EC Project Code: 825162
    Overall Budget: 9,640,780 EURFunder Contribution: 9,640,780 EUR
    Open Access mandate for Publications and Research Data
    Partners: Utrecht University, UB, UPM, SYNAPSE RESEARCH MANAGEMENT PARTNERS SL, UM, UCPH, Medical University of Sofia, Zorginstituut Nederland, TLV, EURORDIS - EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION...

    HTx will create a framework for next generation Health Technology Assessment (HTA) that supports patient-centred, societally oriented, and real-time decision-making for integrated healthcare throughout Europe. HTx will focus on therapeutic areas with high unmet need for...

  • project . 2022 - 2025
    Funder: EC Project Code: 101058620
    Overall Budget: 14,866,400 EURFunder Contribution: 14,866,400 EUR
    Open Access mandate for Publications and Research Data
    Partners: FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE, WU, BBMRI-ERIC, EATRIS, CIRC, UMINHO, EURO-BIOIMAGING ERIC, INSTRUCT-ERIC, Infrafrontier, UNITO...

    canSERVs mission is to make cutting-edge and customised research services available to the cancer research community EU wide, enable innovative R&D projects and foster precision medicine for patients benefit across Europe. By connecting, coordinating, and aligning exist...

  • project . 2017 - 2023
    Funder: EC Project Code: 116106
    Overall Budget: 22,724,600 EURFunder Contribution: 12,000,000 EUR
    Open Access mandate for Publications
    Partners: Bayer AG, Chalmers University of Technology, ANTAROS MEDICAL AB, University of Leeds, Bayer Pharma AG, MERCK SHARP & DOHME CORP, TRULY LABS AB, BRUKER, University of Sheffield, Novo Nordisk...

    1.Our consortium has broad, deep experience of drug development and imaging biomarker (IB) validation. We are internationally recognized experts in transporter biology, animal models of lung injury, toxicology, DCEMRI, compartmental modeling, 1H&129Xe lung MR, and label...

12 projects, page 1 of 3
Any information missing or wrong?Report an Issue